Charles River Laboratories International, Inc.
CRLDiagnostics & Research
$359.41−4.44%As of Oct 30vs prior close
- Market cap
- $17.2B
- P/E (TTM)
- –
- P/E (FY1)
- 31.6×
- From 52W high
- −4.44%
- EPS (LTM)
- -$4.80
- Revenue (LTM)
- $4B
- Net margin
- -5.96%
- Dividend yield
- 0.00%
Nomior Score
49
Steady ProfileBottom 48% of the scored universe
Growth45
Quality43
Value48
Momentum87
Resilience28
Growth
+10.16%revenue a year over 9 fiscal years
YE16 $1.7BLTM $4B
Connections
Revenue to profitQ2 YE26
Who owns it
5funds, 2 tracked portfolios